CGH-53746-84054
3 vaccinations
5 coded responses
30 check-ins
5 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 190 / PA
- Registered
- 2020-12-28
- Relationship
- Self
- Race
- Asian
- Ethnicity
- Not Hispanic or Latino
Registered dependents
CJU-16674-72047
Child or adolescent in my care · Male · 2021-11-07
FZ5-89734-38166
Child or adolescent in my care · Male · 2022-06-24
Timeline
-
2020-12-28
Registered in v-safe
-
2020-12-28
Dose 1 — Moderna
- 2020-12-28
-
2020-12-29
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain, Redness, Swelling · Fatigue or tirednessAdult check-in
-
2020-12-30
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain, Redness, Swelling · ChillsAdult check-in
-
2020-12-31
Survey response — days 1–6 daily, dose 1MedDRA: Erythema, Induration, Pain, Tenderness — Feeling: Good · Site: Pain, Redness, SwellingFree text: The redness and induration is the same but pain and tenderness is improvingMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-01
Survey response — days 1–6 daily, dose 1MedDRA: Arthralgia, Muscle tightness — Feeling: Good · Site: Pain, Swelling · ChillsFree text: Left arm (injection arm) muscle tightness, hurts when externally rotate left shoulder. Unclear if related to exercise the day beforeMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-02
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain, Swelling · ChillsAdult check-in
-
2021-01-03
Survey response — days 1–6 daily, dose 1MedDRA: Lymphadenopathy, Self-medication — Feeling: Good · Site: Pain, SwellingFree text: Axillary lymphadenopathy on injection side. Slightly improved from yesterday. Had to use pain relieversMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-04
Survey response — day 7, dose 1MedDRA: Immediate post-injection reaction, Injection site erythema, Injection site induration, Injection site swelling, Lymphadenopathy — Feeling: Good · Site: Pain, Redness, SwellingFree text: The redness and induration at the injection site that happened right after improved and essentially resolved. Then this morning it came back and is eythematous, indurated, and swollen again. No systemic symptoms. Axillary lymphadenopathy essentially resolved now.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-11
Survey response — day 14, dose 1MedDRA: Injection site erythema — Feeling: GoodFree text: On day 7-9 I had a reoccurrence of erythematous injection site reaction. It grew much larger than the initial reaction and then resolved on its own by day 9. MinimalSystemic symptoms.Maybe some chills.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-01-18
- 2021-01-25
-
2021-01-27
Dose 2 — Moderna
- 2021-01-27
-
2021-01-29
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Fever · Chills, Muscle or body achesAdult check-in
- 2021-01-30
- 2021-01-31
- 2021-02-01
- 2021-02-02
- 2021-02-03
- 2021-02-10
- 2021-02-18
- 2021-03-03
- 2021-03-10
- 2021-04-28
-
2021-10-26
Dose 3 — Moderna
- 2021-11-07
- 2021-11-09
- 2021-11-16
- 2021-11-23
- 2021-11-30
- 2022-01-25
- 2022-04-26
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-28 | Moderna | |
| 2 | 2021-01-27 | Moderna | |
| 3 | 2021-10-26 | Moderna | No |
Free text
Release 1 — days 1–6 daily, dose 1
Systemic reaction (other): The redness and induration is the same but pain and tenderness is improving
Systemic reaction (other): Left arm (injection arm) muscle tightness, hurts when externally rotate left shoulder. Unclear if related to exercise the day before
Systemic reaction (other): Axillary lymphadenopathy on injection side. Slightly improved from yesterday. Had to use pain relievers
Release 1 — day 7, dose 1
Systemic reaction (other): The redness and induration at the injection site that happened right after improved and essentially resolved. Then this morning it came back and is eythematous, indurated, and swollen again. No systemic symptoms. Axillary lymphadenopathy essentially resolved now.
Release 1 — day 14, dose 1
Symptoms: On day 7-9 I had a reoccurrence of erythematous injection site reaction. It grew much larger than the initial reaction and then resolved on its own by day 9. MinimalSystemic symptoms.Maybe some chills.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Injection site erythema | ✓ | ✓ | ✓ |
| SRO | Arthralgia | ✓ | ✓ | ✓ |
| SRO | Erythema | ✓ | ✓ | ✓ |
| SRO | Immediate post-injection reaction | ✓ | ✓ | ✓ |
| SRO | Induration | ✓ | ✓ | ✓ |
| SRO | Injection site erythema | ✓ | ✓ | ✓ |
| SRO | Injection site induration | ✓ | ✓ | ✓ |
| SRO | Injection site swelling | ✓ | ✓ | ✓ |
| SRO | Lymphadenopathy | ✓ | ✓ | ✓ |
| SRO | Muscle tightness | ✓ | ✓ | ✓ |
| SRO | Pain | ✓ | ✓ | ✓ |
| SRO | Self-medication | ✓ | ✓ | ✓ |
| SRO | Tenderness | ✓ | ✓ | ✓ |
| SRO | Unevaluable event | ○ | ○ | ○ |
✓ active code · ○ coded but marked inactive · blank = not in that release